Description:
On Thursday, June 11, 2020 at 1:00 PM Eastern, the Association for Molecular Pathology (AMP) held a virtual town hall on diagnostic testing for COVID-19. AMP presented key preliminary findings from a recent COVID-19 survey of laboratories. This webinar discusses various aspects of COVID-19 molecular diagnostic testing including:
- Current and anticipated testing capacity
- Testing turn-around times
- Supply chain issues
- Test performance and validation
- Processes for United States (US) public health reporting
Initial data presented was gathered from over 100 US-based laboratories including academic medical centers, commercial reference laboratories, and community hospitals or health system laboratories. Additionally, the webinar includes timely policy recommendations based on the survey’s findings, which aim to effectively leverage America’s large and diverse laboratory network to best respond to the coronavirus pandemic.
| 
|
|---|---|
| Speaker Frederick S. Nolte, PhD | Speaker Karen L. Kaul, MD, PhD |
 |  |
| Speaker Jordan Laser, MD | Moderator Karen E. Weck, MD |
Duration: 1 hr
Level of Instruction: Basic
Recording Date: June 11, 2020
CME, CMLE, or SAMs is NOT available for this webinar.
A second survey was sent out in August of 2020 and a town hall on the findings from this survey was given in October of 2020. The recording for this town hall can be found here.
Note: Join the AMP Family for discounted access to many educational resources!
All sales are final. No refunds will be issued.
No digital files may be reproduced or transmitted in any form, by any means, electronic or mechanical. By purchasing a product, you agree to not share any of the course materials, including videos, downloadable slide presentations, outlines, manuscripts, etc. without explicit and written permission from AMP.
